Budesonide 400mcg + Formoterol 6mcg rotacap is a combination inhalation therapy designed for the effective management of asthma and COPD, helping maintain airway function and reduce respiratory distress.
Budesonide provides anti-inflammatory corticosteroid activity, controlling airway inflammation, while Formoterol delivers long-acting bronchodilation, relaxing bronchial smooth muscles for improved airflow.
This rotacap is commonly prescribed for maintenance therapy in asthma, chronic bronchitis, and COPD, aiding in prevention of exacerbations, reducing symptoms like wheezing and breathlessness, and improving quality of life.
With clinically proven efficacy, dual-action mechanism, and patient-friendly administration, this formulation strengthens a respiratory therapy product portfolio and ensures consistent therapeutic demand.